CellCept 500 mg – Composition, Uses and Medicine Enquiries
Product Overview
CellCept 500 mg contains Mycophenolate mofetil, an immunosuppressant medicine used in combination with other prescribed medicines to help prevent rejection following certain organ transplants.
After a transplant, the body’s immune system may recognise the transplanted organ as foreign and attempt to attack it. Mycophenolate mofetil reduces the activity and multiplication of certain immune cells involved in this response. This helps reduce the risk of organ rejection as part of an individualised transplant treatment plan.
Treatment with CellCept requires specialist supervision and regular medical monitoring. The appropriate treatment regimen depends on the type of transplant, the patient’s medical history, other medicines and the treating specialist’s assessment.
Composition and Strength
The supplied product information identifies the following composition:
| Active Ingredient | Strength |
|---|---|
| Mycophenolate mofetil | 500 mg |
Brand Name: CellCept
Generic Name: Mycophenolate mofetil
Strength: 500 mg
Please verify the exact formulation, dosage form and manufacturer details against the original product packaging before proceeding with an enquiry.
Therapeutic Category and Indication
CellCept 500 mg belongs to the immunosuppressant category and is classified as an antimetabolite.
Its clinical use relates to the prevention of rejection following certain organ transplants. It reduces the activity of immune cells that may otherwise attack the transplanted organ.
The medicine is generally used alongside other immunosuppressive treatments as part of a transplant specialist’s prescribed regimen. Treatment decisions depend on the type of transplant, patient-specific factors, coexisting conditions, possible medicine interactions and applicable prescribing guidelines.
The indication provided here is a general overview, not a substitute for a prescriber’s assessment. The exact approved uses, restrictions and treatment protocols should be checked against the current local prescribing information.
Administration Information
CellCept 500 mg should be taken orally exactly as prescribed by the treating transplant specialist.
Patients should follow the prescribed instructions concerning timing and food. Tablets should be swallowed whole and should not be crushed or altered unless specifically directed by an appropriate healthcare professional.
The prescribed schedule, duration, missed-dose instructions and monitoring requirements must be provided by the treating clinician. Patients should not start, interrupt, change or substitute their treatment without specialist advice.
Product Presentation and Availability
The product enquiry can be made using the following details:
- Product Name: CellCept 500 mg
- Generic Name: Mycophenolate mofetil
- Strength: 500 mg
- Therapeutic Category: Immunosuppressant
- Medicine Class: Antimetabolite
- Indication: Prevention of rejection after certain organ transplants
The dosage form, manufacturer, pack size and actual product presentation must be confirmed against the manufacturer’s labelled packaging. Packaging, batch identification, expiry date and remaining shelf life may vary.
A product listing does not confirm current stock, price, availability or eligibility for supply to a particular destination.
Prescription and Patient Safety
CellCept is a prescription immunosuppressant medicine and must be used under the supervision of an appropriately qualified transplant specialist.
Treatment may require regular blood tests and monitoring for infections, low blood-cell counts and other adverse effects. Patients should inform their healthcare professional about their medical history and all other medicines they are taking.
Pregnancy-related safety: Mycophenolate can cause serious harm to an unborn baby and is associated with an increased risk of pregnancy loss and birth defects. Strict pregnancy-prevention precautions and specialist counselling are essential for patients who could become pregnant. Patients should discuss reproductive safety, contraception and pregnancy planning with their treating specialist before and during treatment, as applicable.
Patients should seek medical advice if they experience concerning symptoms or suspect an adverse reaction. Website information must not be used as a substitute for professional medical advice or the current approved prescribing information.
Medicine Enquiry Coordination Through Medinglobal
Medinglobal provides medicine information, product identification and enquiry coordination. Where appropriate, Medinglobal may help patients, caregivers and eligible healthcare organisations communicate with independent, appropriately authorised pharmaceutical suppliers or service providers.
Medinglobal does not manufacture, stock, sell, dispense or prescribe CellCept through the website. Any regulated pharmaceutical activity, including prescription verification and lawful supply, remains the responsibility of the relevant independent provider and is subject to applicable laws and regulations.
Availability, prescription requirements, lawful supply routes, supporting documents and destination-country restrictions must be confirmed before any transaction. Submitting an enquiry does not guarantee supply or availability.
How to Submit a CellCept 500 mg Enquiry
To help identify the requested product, include the following details when submitting an enquiry:
- Product or brand name: CellCept 500 mg.
- Generic name: Mycophenolate mofetil.
- Required strength and dosage form.
- Required quantity.
- Destination country.
- Prescription or supporting documentation, where applicable.
Medinglobal may review the submitted details for identification and coordination purposes and, where appropriate, refer the enquiry to an authorised independent provider. The provider is responsible for its own verification, regulatory checks and any subsequent supply decision.
Frequently Asked Questions
What is CellCept 500 mg used for?
CellCept 500 mg is used with other medicines to help prevent rejection following certain organ transplants. Its use must be determined by a qualified transplant specialist.
What is the generic name of CellCept 500 mg?
The generic name is Mycophenolate mofetil.
What is the strength of CellCept listed on this page?
The supplied product information identifies Mycophenolate mofetil 500 mg. The exact formulation should be verified against the original product packaging.
Does CellCept require medical supervision?
Yes. It is a prescription immunosuppressant medicine that requires specialist supervision and appropriate medical monitoring.
Are there pregnancy-related precautions with CellCept?
Yes. Mycophenolate can cause serious harm during pregnancy. Strict reproductive safety precautions and specialist counselling are essential.
Can international patients submit a CellCept enquiry through Medinglobal?
International enquiries may be submitted. Any coordination or subsequent supply depends on confirmation by an authorised independent provider and compliance with applicable regulations in the relevant countries.
Does Medinglobal sell or dispense CellCept directly?
No. Medinglobal provides product information, identification and enquiry coordination. It does not itself manufacture, sell, dispense or prescribe the medicine through the website.
Important Pharmaceutical Disclaimer
The information on this page is provided for general educational purposes, product identification and medicine enquiry coordination only. It is not medical advice, a treatment recommendation or an offer for sale by Medinglobal. Product details and availability must be verified with the relevant authorised provider. Prescription medicines should be used only under the supervision of an appropriately qualified healthcare professional. Any regulated pharmaceutical activity is subject to applicable laws and regulations.
Reviews
There are no reviews yet.